Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb
Prospective Observational Study Characterizing Noninvasive Hemoglobin (SpHb) Measured With Pulse CO-Oximetry Technology in a Variety of Surgical Cases
1 other identifier
observational
621
1 country
1
Brief Summary
This protocol is a request from Masimo to assist in the collection of data to be used to further refine the accuracy of the monitor's algorithm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2013
CompletedStudy Start
First participant enrolled
November 26, 2013
CompletedFirst Posted
Study publicly available on registry
November 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2024
CompletedApril 9, 2025
November 1, 2024
10.9 years
November 1, 2013
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Masimo Rainbow technology to arterial blood samples taken during surgery
Correlation between standard, lab-based, hemoglobin measurement and concurrent SpHb.
Five year
Interventions
In addition to the standard pulse oximeter used for clinical care, up to six SpHb finger sensors will be applied to the patient. Additional sensors may also be applied to the forehead, neck, chest and ears. Masimo FDA cleared pulse CO-Oximeter devices: Radical-7, Rad-87, Rad-57, Pronto, Pronto-7, for the noninvasive measurement of SpO2, PR, PI, PVI, SpCO, SpMet, and SpHb, total hemoglobin and respiratory rate. No treatment decisions will be made based on the new technology and no extra medical procedures are required for the study.
4mL arterial blood samples (up to 1 per hour), outside standard of care, are drawn throughout the surgical procedure and sent to UCDMC lab/Masimo lab for analysis.
Eligibility Criteria
Patients scheduled for elective surgery.
You may qualify if:
- Patients scheduled for elective surgery requiring intra-arterial pressure monitoring
You may not qualify if:
- Age less than 18 years
- Pregnancy
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC Davis Health
Sacramento, California, 95817, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neal Fleming, M.D., Ph.D.
Professor, Director, Cardiovascular and Thoracic Anesthesiology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2013
First Posted
November 28, 2013
Study Start
November 26, 2013
Primary Completion
October 21, 2024
Study Completion
October 21, 2024
Last Updated
April 9, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share